Skip Site Navigation
Skip To Page Content

Financial Disclosure

Requirement

  • Signed and dated FDA Financial Disclosures for all clinical investigators listed on the form FDA 1572 (drug) or IRB application (device).

QI Tips/Additional Information

  • If FDA Financial Disclosures are filed separately, write a signed and dated note indicating the location.
  • Any applicant (usually a pharmaceutical/device company) who submits a marketing application for a human drug, biological product, or device is required to submit a completed Form FDA 3455 to the FDA for each clinical investigator who participates in a covered study. This form attests to the absence of financial interests, or discloses the nature of any financial arrangements.
  • Everyone listed on the Form FDA 1572 (drug) or IRB application (device) shall provide to the sponsor sufficient accurate financial information on Form FDA 3455. The investigator should promptly update this information if any relevant changes occur in the course of the study, or for one year following completion of the study.
  • A copy of Form FDA 3455 can be found here.

University Block N Logo

University of Nevada, Reno

University of Nevada, Reno
1664 N. Virginia Street
Reno,  NV  89557-

(775) 784-1110
Website Help
Contact Us

Copyright
Privacy
Accessibility Tools

Emergency Information
Emergency Alerts
Doing business with us